Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Essen Biotech
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Mayo Clinic
City of Hope Medical Center
Indapta Therapeutics, INC.
University of Maryland, Baltimore
European Myeloma Network B.V.
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Allogene Therapeutics
Shanxi Province Cancer Hospital
Oncotherapeutics
European Myeloma Network B.V.
Fondazione EMN Italy Onlus
Amgen
Fred Hutchinson Cancer Center
Mayo Clinic
University of Maryland, Baltimore
Henan Cancer Hospital
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Mayo Clinic
Masonic Cancer Center, University of Minnesota
University of Washington
University of Leeds
H. Lee Moffitt Cancer Center and Research Institute
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
UMC Utrecht
King's College Hospital NHS Trust
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
H. Lee Moffitt Cancer Center and Research Institute
Millennium Pharmaceuticals, Inc.
University of Kentucky